Tag Archives: immunotherapy

One month ago we discussed how the CRISPR genome-editing tool offers promise in cancer immunotherapy. The revolutionary gene-editing technology CRISPR-Cas9 is often described as “molecular scissors” for its ability to turn previously improbable feats of genetic engineering into exercises in … Continue reading

Posted in Clinical Trials, Genetic Screening & Testing, Information Strength, Research News, We Live You®: The Latest | Tagged , , , , | Comments Off

The US Food & Drug Administration approved the first ever cancer drug that treats specific genetic traits of the disease, rather than the part of the body in which the cancerous tumor is located, as reported by the Los Angeles … Continue reading

Posted in Clinical Trials, Genetic Screening & Testing, Information Strength, Research News, We Live You®: The Latest | Tagged , , , , | Comments Off

Earlier today we posted a column discussing the first use of the gene editing technique CRISPR-Cas9 in a patient with late-stage throat cancer, in hopes of eradicating the disease. This report from the Memorial Sloan-Kettering Cancer Center in New York, … Continue reading

Posted in Genetic Screening & Testing, Information Strength, International Authority, Research News, We Live You®: The Latest | Tagged , , , , | Comments Off

Offering hope for the New Year comes this story. A new cancer treatment called CAR-T cell immunotherapy has for the first time been found to work in a solid tumor cancers, offering hope this technique could be used to target … Continue reading

Posted in Clinical Trials, Information Strength, Research News, We Live You®: The Latest | Tagged , , | Comments Off

We recently posted a number of columns discussing the promise of immunotherapy. Now comes a report from the Washington Post indicating that for the first time, immunotherapy has been given the green light as an initial treatment for lung cancer, … Continue reading

Posted in Chemotherapy, Clinical Trials, Information Strength, Research News, We Live You®: The Latest | Tagged , , , | Comments Off

After a long, intense pursuit, researchers are close to bringing to market a daring new treatment: cell therapy that turbocharges the immune system to fight cancer, in this report from the New York Times. …cell therapy gives each patient an … Continue reading

Posted in Clinical Trials, Information Strength, Research News, We Live You®: The Latest | Tagged , , | Comments Off

As part of their series exploring the novel uses of immunotherapy to combat cancer, the New York Times provides the answers to frequently asked questions at this link. Included are answers to questions such as: How well does immunotherapy work? … Continue reading

Posted in Clinical Trials, Information Strength, Online Resource, Research News, We Live You®: The Latest | Tagged , | Comments Off

. Jim Allison, Ph.D., is an M.D. Anderson researcher whose ground breaking research enabled doctors to enlist the immune system to fight cancer. Dr. Allison is mentioned in yesterday’s column, and is prominently featured in the New York Times in-depth … Continue reading

Posted in Clinical Trials, Information Strength, Video, We Live You®: The Latest | Tagged , , | Comments Off